Streetbeat News

Analyst Ratings

WWD

UBS analyst Gavin Parsons has reaffirmed a Buy rating on Woodward (NASDAQ:WWD) and increased the price target from $168 to $177.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:21 pm

WRB

UBS analyst Brian Meredith has maintained a Buy rating on WR Berkley (NYSE:WRB) and increased the price target from $81 to $93.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:20 pm

FCNCA

UBS analyst Brody Preston has reaffirmed a Buy rating on First Citizens BancShares (NASDAQ:FCNCA) and increased the price target from $1644 to $1754.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:18 pm

ALGN

UBS analyst Kevin Caliendo has maintained a Neutral rating on Align Technology (NASDAQ:ALGN) and increased the price target from $200 to $260.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:16 pm

ABNB

Wedbush analyst Scott Devitt has maintained a Neutral rating on Airbnb (NASDAQ:ABNB) but increased the price target from $135 to $150. This adjustment reflects a more positive outlook on the company's valuation while not fully committing to a buy or sell recommendation.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:14 pm

BKNG

Wedbush analyst Scott Devitt has reiterated an Outperform rating on Booking Holdings (NASDAQ:BKNG) and maintained a price target of $3850 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:11 pm

HXL

UBS analyst Gavin Parsons downgraded Hexcel (NYSE:HXL) from Buy to Neutral and reduced the price target from $87 to $72.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:07 pm

UPWK

JMP Securities analyst Andrew Boone has reiterated a 'Market Outperform' rating on Upwork (NASDAQ:UPWK) and maintained a price target of $16. This reaffirmation of Upwork's stock performance and price target suggests continued confidence in the company's potential for growth and market performance.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 5:01 pm

ZG

Over the past three months, 8 analysts have provided diverse opinions on Zillow Group (NASDAQ:ZG), with ratings ranging from bullish to indifferent. The average 12-month price target is $55.75, with a high of $66.00 and a low of $36.00, marking a 5.11% decrease in the average target. Analysts from firms like RBC Capital, Benchmark, JMP Securities, Deutsche Bank, Susquehanna, and Piper Sandler have adjusted their ratings and price targets, reflecting their latest views on the company's performance. Zillow Group operates in real estate and has shown a revenue growth rate of 2.69% as of September 30, 2023, but struggles with a net margin of -5.65%. The company's ROE and ROA outperform industry averages, and it maintains a healthy debt-to-equity ratio of 0.42.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 5:01 pm

GH

Guardant Health (NASDAQ:GH) received mixed analyst ratings in the latest quarter, with 2 bullish and 2 somewhat bullish ratings. The average 12-month price target is now $37.75, down from $47.00. Analysts from Goldman Sachs, Raymond James, and Morgan Stanley adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Guardant Health is known for its liquid-based cancer tests and has shown a revenue growth rate of 21.83% as of September 30, 2023. However, the company faces challenges with a net margin of -60.2%, ROE of -33.05%, ROA of -4.73%, and a high debt-to-equity ratio of 5.95.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 5:01 pm